[University home]

School of Medicine

Dr Anthony Oliver PhD, BSc (Hons)

Photograph of Anthony Oliver

Research Associate


 

Role

I am currently working on a variety of projects in the area of basic cancer research, based within the Viral Oncology Group at St Mary's Hospital.

Current Research Interests

  • The role of human viruses in cancer
  • Identification of new cancer diagnostic and prognostic markers (Vibio Limited)
  • Development of novel cancer therapeutics

I am actively involved in Health and Safety issues within the University and hold positions on the following Committees:

  • St Mary's Genetic Modification and Biohazards Committee (Deputy Chair)
  • St Mary's Research Floor Health & Safety Committee
 

Research

Current Research Interests

  • The role of human viruses in cancer
  • Identification of new cancer diagnostic and prognostic markers
  • Development of novel cancer therapeutics

Recent Press Releases / News Articles from The Viral Oncology Group:

 

 
 
http://www.youtube.com/watch?v=JVSfeYAqmUM ( BBC1, North West Tonight )
 
 

Qualifications

PhD in Medical Oncology from the University of Manchester.

 
BSc (Hons) Biochemistry, UMIST 
 

Publications

2011

  • Batman G, Oliver AW, Zehbe I, Richard C, Hampson L, Hampson IN. (2011). Lopinavir up-regulates expression of the antiviral protein ribonuclease L in human papillomavirus-positive cervical carcinoma cells. Antiviral Therapy, 16(4), 515-525. eScholarID:125326 | DOI:10.3851/IMP1786
  • Hampson IN, Oliver AW, Hampson L. (2011). Targeting activated Rho proteins: a new approach for treatment of HPV and other virus-related cancers? Expert Review of Anticancer Therapy, 11(7), 975-978. eScholarID:130260 | DOI:10.1586/era.11.86
  • Oliver, A., He, X., Borthwick, K., Donne, A., Hampson, L. & Hampson, I (2011). The HPV16 E6 binding protein Tip-1 interacts with ARHGEF16, which activates Cdc42. Br J Cancer, 104(2), 324-31. eScholarID:118330 | PMID:21139582 | DOI:10.1038/sj.bjc.6606026

2010

  • Kim, D., Jarvis, R., Xu, Y., Oliver, A., Allwood, J., Hampson, L., Hampson, I. & Goodacre, R (2010). Combining metabolic fingerprinting and footprinting to understand the phenotypic response of HPV16 E6 expressing cervical carcinoma cells exposed to the HIV anti-viral drug lopinavir. Analyst, 135(6), 1235-44. eScholarID:118331 | PMID:20390218 | DOI:10.1039/b923046g

2009

  • Hampson L, He XT, Oliver AW, Hadfield JA, Kemp T, Butler J, McGown A, Kitchener HC, Hampson IN. (2009). Analogues of Y27632 increase gap junction communication and suppress the formation of transformed NIH3T3 colonies. British Journal of Cancer, 1;101(5), 829-839. eScholarID:121049

2004

  • Hampson, L., Li, C., Oliver, A., Kitchener, H. & Hampson, I (2004). The PDZ protein Tip-1 is a gain of function target of the HPV16 E6 oncoprotein. Int J Oncol, 25(5), 1249-56. eScholarID:118333 | PMID:15492812

Top of page